Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.120 | 2 | 111074216 | intron variant | T/C | snv | 0.13 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||||
|
0.925 | 0.120 | 2 | 111074216 | intron variant | T/C | snv | 0.13 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 2 | 2016 | 2017 | |||||||
|
1.000 | 0.040 | 2 | 110841146 | intron variant | A/G | snv | 1.3E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 2 | 111098716 | non coding transcript exon variant | A/G | snv | 0.26 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 2 | 111098716 | non coding transcript exon variant | A/G | snv | 0.26 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 2 | 111098716 | non coding transcript exon variant | A/G | snv | 0.26 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 2 | 111098716 | non coding transcript exon variant | A/G | snv | 0.26 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 2 | 110842942 | intron variant | C/T | snv | 0.18 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 2 | 110840414 | intron variant | A/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 2 | 110841381 | missense variant | C/A;T | snv | 4.1E-06; 0.19 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 2 | 110841822 | intron variant | G/C;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.120 | 2 | 111061081 | intron variant | A/C | snv | 0.25 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 2 | 111061081 | intron variant | A/C | snv | 0.25 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 2 | 110842024 | intron variant | A/G | snv | 0.26 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.160 | 2 | 110842129 | intron variant | G/A | snv | 0.44 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 2 | 110839714 | intron variant | C/T | snv | 7.5E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
2 | 111049969 | intron variant | G/C | snv | 5.0E-03 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 2 | 110842942 | intron variant | C/T | snv | 0.18 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
2 | 111034076 | intron variant | C/T | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
2 | 111034076 | intron variant | C/T | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 2 | 110922578 | intron variant | T/C | snv | 0.31 |
|
Eye Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.040 | 2 | 111005349 | intron variant | C/T | snv | 0.36 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.040 | 2 | 111005349 | intron variant | C/T | snv | 0.36 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
2 | 110907179 | intron variant | A/G | snv | 0.33 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
2 | 111111114 | intron variant | T/A | snv | 7.3E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 |